Bio-Rad Acquires Curiosity Diagnostics from Scope Fluidics

Bio-Rad Laboratories (Hercules, CA, USA) has reached an agreement to acquire all of the outstanding shares of Curiosity Diagnostics, Sp. Z. o. o. from Scope Fluidics, S.A. (Warsaw, Poland) for a total consideration of up to USD 170 million, consisting of approximately USD 100 million in cash, and up to USD 70 million in future milestone payments.

Curiosity Diagnostics, a late-stage, pre-commercial platform company, is in the process of developing a sample-to-answer, rapid diagnostics PCR system for the molecular diagnostics market.

“We are excited to have the Curiosity Diagnostics team join Bio-Rad’s Clinical Diagnostics Group and to work closely together to bring a new generation of rapid PCR systems to market,” said Dara Wright, Bio-Rad’s EVP and President, Clinical Diagnostics Group. “Curiosity’s PCR platform, PCR|ONE, offers a streamlined workflow and rapid turnaround times, and is expected to extend our reach beyond high-complexity labs into near-patient molecular diagnostics labs.”

“Our passion at Scope Fluidics is developing innovative technologies addressing the greatest challenges in global health,” added Scope Fluidics President and co-founder, Professor Piotr Garstecki. “The dedicated, entrepreneurial team of highly skilled, specialized personnel of Curiosity Diagnostics is looking forward to further developing the PCR|ONE technology under Bio-Rad’s leadership while we at Scope Fluidics continue to pursue new and current projects in disruptive medical diagnostics.”

Related Links:
Bio-Rad Laboratories 
Scope Fluidics, S.A.

Visit expo >

New

Gold Supplier

Human Chorionic Gonadotropin (hCG) Test

OSOM hCG Combo Test

New

Lactose Intolerance Test

Lactose Intolerance LCT Kit

New

Automated Nucleic Acid Extraction System

GenoXtract fleXT

New

Gold Supplier

Bartonella Immunofluorescence Assay

BARTONELLA IFA